Minerva Neurosciences, Inc. (NERV) vs Quanterix Corporation (QTRX)
A side-by-side comparison of Minerva Neurosciences, Inc. and Quanterix Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NERV
Minerva Neurosciences, Inc.
$3.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
QTRX
Quanterix Corporation
$3.44HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NERV vs QTRX
growth of $100 · dividends reinvested · last 9yNERV -92.6% (-25.1%/yr)QTRX -78.2% (-15.6%/yr)QTRX compounded faster over this window
NERV QTRX
NERV vs QTRX: by the numbers
- •QTRX is the larger company ($162M vs $160M market cap).
- •Both run net losses; NERV's is the smaller (0.00% vs -80.29% net margin).
Metrics side by side
Valuation
| Metric | NERV | QTRX |
|---|---|---|
| P/S ratio | N/A | 1.06 |
| P/B ratio | N/A | 0.68 |
Profitability
| Metric | NERV | QTRX |
|---|---|---|
| Gross margin | 0.00% | 42.60% |
| Operating margin | 0.00% | -86.19% |
| Net margin | 0.00% | -80.29% |
| ROE | N/A | -51.90% |
| ROIC | -38.56% | -49.08% |
Growth (annualized)
| Metric | NERV | QTRX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.23% |
| Total return CAGR (5Y) | -22.14% | -39.63% |
Frequently asked
- How have NERV and QTRX total returns compared?
- Over the past 5 years, NERV delivered -22.14% and QTRX delivered -39.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.